Priority Date: 08.06.12 (US 201261657484P)

MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER

  • Application ID: EP13729649
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
Technology Company

Specialization

This patent has the IPC combination A61, C12, and G01 is specialized in the combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP and 78 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 08.06.2012 - Priority Date (US 201261657484P)
  • 12.12.2013 - Publication A1 (WO2013182668)
  • 15.04.2015 - Publication A1 (EP2858666)